{"id":"W4402890485","doi":"10.1177/17562864241281903","title":"Risk of major adverse cardiovascular events and all-cause mortality under treatment with GLP-1 RAs or the dual GIP/GLP-1 receptor agonist tirzepatide in overweight or obese adults without diabetes: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Liraglutide; Semaglutide; Internal medicine; Mace; Overweight; Odds ratio; Diabetes mellitus; Type 2 diabetes; Placebo; Dulaglutide; Myocardial infarction; Population; Glucagon-like peptide 1 receptor; Endocrinology; Adverse effect; Obesity; Agonist; Receptor; Percutaneous coronary intervention","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008478959,0.00104266,0.008182822,0.000290637,0.00006262141,0.00002473119,0.0002378627,0.000187076,0.0001226997],"category_scores_gemma":[0.0001075941,0.0003615253,0.001814506,0.00114445,0.0003776384,0.0001336878,0.0001523354,0.0004130514,0.000007218878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001010914,"about_ca_system_score_gemma":0.00007483629,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008166599,"about_ca_topic_score_gemma":0.001247032,"domain_scores_codex":[0.994672,0.001689884,0.001341267,0.001186868,0.0005966389,0.0005133412],"domain_scores_gemma":[0.9972081,0.0008015996,0.0006573873,0.001159035,0.00003659855,0.0001372745],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0004839648,0.001034157,0.003630353,0.3561097,0.6107957,0.0001424813,0.0001504549,0.0000383537,1.280615e-8,0.00003966788,0.000004110809,0.02757099],"study_design_scores_gemma":[0.001786388,0.002222041,0.0004531509,0.01146069,0.9659539,0.000008585625,0.00008439146,0.0000529376,5.975019e-8,0.0001295506,0.01742703,0.0004213068],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002785259,0.9872574,0.00001538993,0.0002756531,0.00003642203,0.009388379,0.0001655069,0.00004407711,0.00003191655],"genre_scores_gemma":[0.004721816,0.990497,0.00008047996,0.0005613744,0.000009893245,0.00366509,0.0001000961,0.00006751413,0.0002967217],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3551581,"threshold_uncertainty_score":0.9998837,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06532569228572091,"score_gpt":0.3519981919897024,"score_spread":0.2866724997039815,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}